-
Early versus periprocedural administration of abciximab for primary angioplasty : a pooled analysis of 6 studiesGödicke, Jochen ...Background: The 2004 ACC/AHA guidelines on ST-elevation myocardial infarction state that it is reasonable to start treatment with abciximab as early as possible before primary percutaneous coronary ... intervention (PCI). We investigated the potential benefit of early use of abciximab by pooling data from all the available studies. Methods: Six prospective studies were identified that had allocated 260 patients to receive early abciximab (either prehospital or soon after the patient arrived in hospital) and 342 to receive late abciximab (at the time of PCI). Results: TIMI flow grade 2 or 3 was present in 42% of the early group compared with 29% in the late group (P = .001). After PCI, 59% of patients in the early group showed ST-resolution >or= 70%, compared with 41% in the late group (P = .003). The composite clinical outcomes death, new myocardial infarction, or repeat target vessel revascularization at 30 days occurred in 7.3% of the early group compared with9.7% in the late group (odds ratio 0.73, 95% CI 0.41-1.32) and death alone occurred in 2.7% versus 4.7%, respectively (odds ratio 0.56, 95% CI 0.23-1.39). Conclusions: Early administration of abciximab improves epicardial patency (TIMI flow) before PCI and results in better myocardial tissue perfusion (ST-resolution) after the procedure. The promising effects onclinical outcomes need to be tested in larger studies.Vir: The American heart journal : international publication for the study of the circulation. - ISSN 0002-8703 (Vol. 150, iss. 5, Nov. 2005, str. 1015.e11-1015.e17)Vrsta gradiva - članek, sestavni delLeto - 2005Jezik - angleškiCOBISS.SI-ID - 24133337
Avtor
Gödicke, Jochen |
Flather, Marcus |
Noč, Marko, 1963- |
Gyöngyösi, Mariann |
Arntz, Hans-Richard |
Grip, Lars |
Gabriel, Henrique Mesquita |
Huber, Kurt |
Nugara, Fiona |
Kržišnik-Zorman, Simona
Teme
Angioplasty, Transluminal, Percutaneous Coronary |
Antibodies, Monoclonal |
Administration & Dosage |
Time Factors |
Angioplastika transluminalna, perkutana, koronarna |
Protitelesa monoklonska |
Časovni faktorji
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Gödicke, Jochen | ![]() |
Flather, Marcus | ![]() |
Noč, Marko, 1963- | 01161 |
Gyöngyösi, Mariann | ![]() |
Arntz, Hans-Richard | ![]() |
Grip, Lars | ![]() |
Gabriel, Henrique Mesquita | ![]() |
Huber, Kurt | ![]() |
Nugara, Fiona | ![]() |
Kržišnik-Zorman, Simona | 11351 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.